How to cite this paper
APA: Kumar, B., Mohana, K., Mallesha, L & Rekha, N. (2013). Synthesis of (E)-2-(arylbenzylidene)-2-((4-methoxyphenyl)amino) acetohydrazide derivatives and their antimicrobial activity. Current Chemistry Letters, 2(4), 167-176.
Chicago/Turabian: Kumar, B., Mohana, K., Mallesha, L & Rekha, N. 2013. "Synthesis of (E)-2-(arylbenzylidene)-2-((4-methoxyphenyl)amino) acetohydrazide derivatives and their antimicrobial activity." Current Chemistry Letters 2, no. 4 (2013): 167-176.
AMA: Kumar, B., Mohana, K., Mallesha, L & Rekha, N. Synthesis of (E)-2-(arylbenzylidene)-2-((4-methoxyphenyl)amino) acetohydrazide derivatives and their antimicrobial activity. Current Chemistry Letters. 2013;2(4):167-176.
References
1 Burger A. (2003) Burger’s Medicinal Chemistry and drug Discovery, 6th Ed, John Wiley & Sons, USA.
2 Sheehan D. J., Hitchcock C. A., and Sibley C. M. (1999) Current and emerging azole antifungal agents. Clin. Microbiol. Rev., 12, 40-79.
3 Jawad A. H., Shneine J. K., Ahmed A., and Abdulrasool M. M. (2012) Synthesis, characterization and evaluation of biological activity of some heterocyclic compounds containing 1,2,4-triazole ring. Int. J. Research Pharm. Chem., 2, 2231-2781.
4 Omar F. A., Mahfouz N. M., and Rahman M. A. (1996) Synthesis, characterization and crystal structure of ethyl-4-(3-chlorobenzamido)benzoate. Eur. J. Med. Chem., 31, 819-825.
5 Gilani S. J., Khan S. A., and Siddiqui N. (2010) Synthesis and pharmacological evaluation of condensed heterocyclic 6-substituted 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazole and 1,3,4-oxadiazole derivatives of isoniazid. Bioorg. Med. Chem. Lett., 20, 4762-4765.
6 Sahin G., Palaska E., Ekizoglu M., and Ozalp M. (2002) Synthesis and antimicrobial activity of some 1,3,4-oxadiazole derivatives. II Farmaco, 57, 539-542.
7 Wang Z., Wang M., Yao X., Li Y., Qioa W., Geng Y., Liu Y., and Wang Q. (2012) Hydroxyl may not be indispensable for rategravir: Design, synthesis and SAR studies of raltegravir derivatives as HIV-I inhibitors. Eur. J. Med, Chem., 50, 361-369.
8 Bondock S., Adel S., Etman H. A., and Badria F. A. (2012) Synthesis and antitumor evaluation of some 1,3,4-oxadiazoles-based hetrocycles. Eur. J. Med. Chem., 48, 192-199.
9 Bankar G. R., Nandakumar K., Nayak P. G., Thalkur A., Chamallamudi M. R., and Nampurat G. K. (2009) Vasorelaxant effect in rat aortic through calcium channel blockage; Apreliminary in vitro assessment of a 1,3,4-oxadiazole deivatives. Chem. Biol. Interact., 181, 377-382.
10 Liu K., Lu X., Zhang H. J., and Sun, H. L. (2012) Synthesis, molecular and biological evaluation of 2-(benzylthio)-5-aryloxadiazoles derivatives as anti-tumar agents. Eur. J. Med. Chem., 47, 473-478.
11 Gosselin F., Britton R. A., Davies I. W., Dolman S. J., Gauvreau D., Hoerrner R., Hughes G., Janey J., Lau S., and Molinaro C. (2010) A practical synthesis of 5-lipoxygenase inhibitors MK-0633. J. Org. Chem., 75, 4154-4160.
12 Liao Y., Bottcher H., Harting J., Greiner H., Amsterdam C. V., Cremers T., Sundell S., Marz J., Rautenberg W., and Wikstrom H. (2000) New selective and potent 5HT antagonists: Chemistry and pharmacological evaluation of N-piperazinylphenyl biphenylcarboxamides and biphenylsulfonamides. J. Med. Chem., 43, 517-525.
13 Chrysina E. D., Kosmopoupou M. N., Tiraidis C., Kardakaris R., Bischler N., Leonidas D. D., Hadady Z., Somsak L., Docsa P., Gergely P., and Oikonomakos N. G. (2005) Kinetic and crystallographic studies on 2-(B-D-glucopyranosyl)-5-methyl-1,3,4-oxadiazole, -benzothiazoleb and –benzimidazole. Protein Sci., 14, 873-888.
14 Huang X. -F., Lu X., Zhang Y., Song G. -Q., He Q. -L., Li Q.-S., Yang X. -H., Wei Y., and Zhu H. -L. (2012) Synthesis, biological evaluation and molecular docking studies of N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)aniline derivatives. Bioorg. Med. Chem., 20, 4895-4900.
15 Francisco M., Garibotto, Maximiliano A., Sortino, Vladimir V., Kouznetsov, Ricardo D., Enriz, and Susana A. Z. (2011) Synthesis and antifungal activity of N-aryl-N-benzylamines and of their homallyl analogues. ARKIVOC, VII, 149-161.
16 Jayashankar B., Lokanath Rai K. M., Baskaran N., and Sathish H. S. (2009) Synthesis and pharmacological evalution of 1,3,4-oxadiazoles bearing bis(hetrocycle) derivatives as anti-inflammatory and analgesic agents. Eur. J. Med. Chem., 44, 3898-3902.
17 Om P., Manoj K., Rajesh K., Chetan S., and Aneja K. R. (2010) Hypervalent iodine (III) mediated synthesis of novel unsymmetrical 2,5-disubstituted 1,3,4-oxadiazoles as antibacterial and antifungal agents. Eur. J. Med. Chem., 45, 4252-4257.
18 Andrews J. M. (2001) BSAC standardized disc susceptibility testing method. J. Antimicrob. Chemother., 48, 43-57.
19 Satish S, Mohana D. C., Raghavendra M. P., and Raveesha K. A. (2007) Antifungal activity of some plant extracts against important seed borne pathogens of aspergillus sp. J. Agri. Tech., 3, 109-119.
2 Sheehan D. J., Hitchcock C. A., and Sibley C. M. (1999) Current and emerging azole antifungal agents. Clin. Microbiol. Rev., 12, 40-79.
3 Jawad A. H., Shneine J. K., Ahmed A., and Abdulrasool M. M. (2012) Synthesis, characterization and evaluation of biological activity of some heterocyclic compounds containing 1,2,4-triazole ring. Int. J. Research Pharm. Chem., 2, 2231-2781.
4 Omar F. A., Mahfouz N. M., and Rahman M. A. (1996) Synthesis, characterization and crystal structure of ethyl-4-(3-chlorobenzamido)benzoate. Eur. J. Med. Chem., 31, 819-825.
5 Gilani S. J., Khan S. A., and Siddiqui N. (2010) Synthesis and pharmacological evaluation of condensed heterocyclic 6-substituted 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazole and 1,3,4-oxadiazole derivatives of isoniazid. Bioorg. Med. Chem. Lett., 20, 4762-4765.
6 Sahin G., Palaska E., Ekizoglu M., and Ozalp M. (2002) Synthesis and antimicrobial activity of some 1,3,4-oxadiazole derivatives. II Farmaco, 57, 539-542.
7 Wang Z., Wang M., Yao X., Li Y., Qioa W., Geng Y., Liu Y., and Wang Q. (2012) Hydroxyl may not be indispensable for rategravir: Design, synthesis and SAR studies of raltegravir derivatives as HIV-I inhibitors. Eur. J. Med, Chem., 50, 361-369.
8 Bondock S., Adel S., Etman H. A., and Badria F. A. (2012) Synthesis and antitumor evaluation of some 1,3,4-oxadiazoles-based hetrocycles. Eur. J. Med. Chem., 48, 192-199.
9 Bankar G. R., Nandakumar K., Nayak P. G., Thalkur A., Chamallamudi M. R., and Nampurat G. K. (2009) Vasorelaxant effect in rat aortic through calcium channel blockage; Apreliminary in vitro assessment of a 1,3,4-oxadiazole deivatives. Chem. Biol. Interact., 181, 377-382.
10 Liu K., Lu X., Zhang H. J., and Sun, H. L. (2012) Synthesis, molecular and biological evaluation of 2-(benzylthio)-5-aryloxadiazoles derivatives as anti-tumar agents. Eur. J. Med. Chem., 47, 473-478.
11 Gosselin F., Britton R. A., Davies I. W., Dolman S. J., Gauvreau D., Hoerrner R., Hughes G., Janey J., Lau S., and Molinaro C. (2010) A practical synthesis of 5-lipoxygenase inhibitors MK-0633. J. Org. Chem., 75, 4154-4160.
12 Liao Y., Bottcher H., Harting J., Greiner H., Amsterdam C. V., Cremers T., Sundell S., Marz J., Rautenberg W., and Wikstrom H. (2000) New selective and potent 5HT antagonists: Chemistry and pharmacological evaluation of N-piperazinylphenyl biphenylcarboxamides and biphenylsulfonamides. J. Med. Chem., 43, 517-525.
13 Chrysina E. D., Kosmopoupou M. N., Tiraidis C., Kardakaris R., Bischler N., Leonidas D. D., Hadady Z., Somsak L., Docsa P., Gergely P., and Oikonomakos N. G. (2005) Kinetic and crystallographic studies on 2-(B-D-glucopyranosyl)-5-methyl-1,3,4-oxadiazole, -benzothiazoleb and –benzimidazole. Protein Sci., 14, 873-888.
14 Huang X. -F., Lu X., Zhang Y., Song G. -Q., He Q. -L., Li Q.-S., Yang X. -H., Wei Y., and Zhu H. -L. (2012) Synthesis, biological evaluation and molecular docking studies of N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)aniline derivatives. Bioorg. Med. Chem., 20, 4895-4900.
15 Francisco M., Garibotto, Maximiliano A., Sortino, Vladimir V., Kouznetsov, Ricardo D., Enriz, and Susana A. Z. (2011) Synthesis and antifungal activity of N-aryl-N-benzylamines and of their homallyl analogues. ARKIVOC, VII, 149-161.
16 Jayashankar B., Lokanath Rai K. M., Baskaran N., and Sathish H. S. (2009) Synthesis and pharmacological evalution of 1,3,4-oxadiazoles bearing bis(hetrocycle) derivatives as anti-inflammatory and analgesic agents. Eur. J. Med. Chem., 44, 3898-3902.
17 Om P., Manoj K., Rajesh K., Chetan S., and Aneja K. R. (2010) Hypervalent iodine (III) mediated synthesis of novel unsymmetrical 2,5-disubstituted 1,3,4-oxadiazoles as antibacterial and antifungal agents. Eur. J. Med. Chem., 45, 4252-4257.
18 Andrews J. M. (2001) BSAC standardized disc susceptibility testing method. J. Antimicrob. Chemother., 48, 43-57.
19 Satish S, Mohana D. C., Raghavendra M. P., and Raveesha K. A. (2007) Antifungal activity of some plant extracts against important seed borne pathogens of aspergillus sp. J. Agri. Tech., 3, 109-119.